Given DRD2-mediated dopamine inhibition of PRL [21], and the elevated PRL blood levels found in PCOS [16], we studied the PRL pathway in PCOS and recently identified the prolactin receptor (PRLR) gene as contributing to PCOS risk [29]. Here, DRD2 is linked to polycystic ovary syndrome.